UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors

Blood cancer journal (New York), 2015-11, Vol.5 (11), p.e366-e366

2015

Volltextzugriff (PDF)

Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients

Blood cancer journal (New York), 2017-12, Vol.7 (12), p.662-662, Article 662

2017

Volltextzugriff (PDF)

Prognostic impact of bone marrow fibrosis in polycythemia vera: validation of the IWG-MRT study and additional observations

Blood cancer journal (New York), 2017-03, Vol.7 (3), p.e538-e538

2017

Volltextzugriff (PDF)

P708: CANADIAN AND RUSSIAN EXPERIENCES OF ASCIMINIB IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS WHO FAILED MULTIPLE LINES OF TYROSINE KINASE INHIBITOR (TKI) THERAPY

HemaSphere, 2022-06, Vol.6, p.603-604

2022

Volltextzugriff (PDF)

Statistical practice in high-throughput screening data analysis

Nature biotechnology, 2006-02, Vol.24 (2), p.167-175

2006

Volltextzugriff (PDF)

Translational Induction of the Inhibitor of Apoptosis Protein HIAP2 during Endoplasmic Reticulum Stress Attenuates Cell Death and Is Mediated via an Inducible Internal Ribosome Entry Site Element

The Journal of biological chemistry, 2004-04, Vol.279 (17), p.17148-17157

2004

Volltextzugriff (PDF)

The eIF4G homolog DAP5/p97 supports the translation of select mRNAs during endoplasmic reticulum stress

Nucleic acids research, 2008-01, Vol.36 (1), p.168-178

2008

Volltextzugriff (PDF)

Efficacité et sécurité d’emploi de l’avapritinib dans la mastocytose systémique indolente (MSI) : résultats de l’étude PIONEER en double aveugle, contrôlée par placebo

Annales de Dermatologie et de Vénéréologie - FMC, 2023-12, Vol.3 (8), p.A80-A81

2023

Volltextzugriff (PDF)

Clinical role of obinutuzumab in the treatment of naive patients with chronic lymphocytic leukemia

Biologics, 2015-01, Vol.9 (default), p.13-22

2015

Volltextzugriff (PDF)

Blastic plasmacytoid dendritic cell neoplasm: challenges and future prospects

Blood and lymphatic cancer, 2017-01, Vol.7, p.85-93

2017

Volltextzugriff (PDF)

Iliac Vein Compression Syndrome in an Active and Healthy Young Female

Case Reports in Medicine, 2012-01, Vol.2012 (2012), p.317-321-282

2012

Volltextzugriff (PDF)

Assessing the Feasibility of Thromboprophylaxis with Apixaban in JAK2-Positive Myeloproliferative Neoplasm Patients: The Airport-MPN Trial

Blood, 2023-11, Vol.142 (Supplement 1), p.1823-1823

2023

Volltextzugriff (PDF)

Azacitidine in the treatment of blastic plasmacytoid dendritic cell neoplasm: a report of 3 cases

Leukemia & lymphoma, 2016-11, Vol.57 (11), p.2720-2722

2016

Volltextzugriff (PDF)

Treatment of Myelofibrosis: A Moving Target

The cancer journal (Sudbury, Mass.), 2016-01, Vol.22 (1), p.51-61

2016

Volltextzugriff (PDF)

A Real-World Canadian Experience of Asciminib Use in Chronic Myeloid Leukemia (CML) Patients Who Failed Multiple Lines of Tyrosine Kinase Inhibitor (TKI) Therapy

Blood, 2021-11, Vol.138 (Supplement 1), p.3610-3610

2021

Volltextzugriff (PDF)

Cytogenetic findings in WHO‐defined polycythaemia vera and their prognostic relevance

British journal of haematology, 2018-08, Vol.182 (3), p.437-440

2018

Volltextzugriff (PDF)

Bendamustine therapy associated resolution of anemia and splenomegaly in myelofibrosis

American journal of hematology, 2016-02, Vol.91 (2), p.E6-E7

2016

Volltextzugriff (PDF)

Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study

Bone marrow transplantation (Basingstoke), 2024-02, Vol.59 (2), p.196-202

2024

Volltextzugriff (PDF)

Perioperative management of myeloproliferative neoplasms: A pan‐Canadian physician survey and international expert opinion

American journal of hematology, 2022-12, Vol.97 (12), p.E466-E469

2022

Volltextzugriff (PDF)

Correction: Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study

Bone marrow transplantation (Basingstoke), 2024-02, Vol.59 (2), p.295-295

2024

Volltextzugriff (PDF)

Avapritinib Improved Skin Findings In Patients With Indolent Systemic Mastocytosis (ISM) In the Registrational, Double-Blind, Placebo Controlled PIONEER Study

Journal of allergy and clinical immunology, 2023-02, Vol.151 (2), p.AB340-AB340

2023

Volltextzugriff (PDF)

Efficacy and Safety of Avapritinib in Indolent Systemic Mastocytosis (ISM): Results from the Double Blinded Placebo-Controlled PIONEER Study

Journal of allergy and clinical immunology, 2023-02, Vol.151 (2), p.AB204-AB204

2023

Volltextzugriff (PDF)

Monocytosis in polycythemia vera: Clinical and molecular correlates

American journal of hematology, 2017-07, Vol.92 (7), p.640-645

2017

Volltextzugriff (PDF)

Canadian real-world experience of asciminib treatment in heavily pre-treated chronic myeloid leukemia (CML) patients who failed multiple lines of tyrosine kinase inhibitor (TKI) therapy

Leukemia research, 2023-10, Vol.133, p.107374-107374, Article 107374

2023

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Aktive Filter

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(35)

Sprache

Englisch
(43)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors

Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients

Prognostic impact of bone marrow fibrosis in polycythemia vera: validation of the IWG-MRT study and additional observations

P708: CANADIAN AND RUSSIAN EXPERIENCES OF ASCIMINIB IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS WHO FAILED MULTIPLE LINES OF TYROSINE KINASE INHIBITOR (TKI) THERAPY

Statistical practice in high-throughput screening data analysis

Translational Induction of the Inhibitor of Apoptosis Protein HIAP2 during Endoplasmic Reticulum Stress Attenuates Cell Death and Is Mediated via an Inducible Internal Ribosome Entry Site Element

The eIF4G homolog DAP5/p97 supports the translation of select mRNAs during endoplasmic reticulum stress

Efficacité et sécurité d’emploi de l’avapritinib dans la mastocytose systémique indolente (MSI) : résultats de l’étude PIONEER en double aveugle, contrôlée par placebo

Clinical role of obinutuzumab in the treatment of naive patients with chronic lymphocytic leukemia

Blastic plasmacytoid dendritic cell neoplasm: challenges and future prospects

Iliac Vein Compression Syndrome in an Active and Healthy Young Female

Assessing the Feasibility of Thromboprophylaxis with Apixaban in JAK2-Positive Myeloproliferative Neoplasm Patients: The Airport-MPN Trial

Azacitidine in the treatment of blastic plasmacytoid dendritic cell neoplasm: a report of 3 cases

Treatment of Myelofibrosis: A Moving Target

A Real-World Canadian Experience of Asciminib Use in Chronic Myeloid Leukemia (CML) Patients Who Failed Multiple Lines of Tyrosine Kinase Inhibitor (TKI) Therapy

Cytogenetic findings in WHO‐defined polycythaemia vera and their prognostic relevance

Bendamustine therapy associated resolution of anemia and splenomegaly in myelofibrosis

Clinical Features and Long-Term Outcomes of a Pan-Canadian Cohort of Adolescents and Young Adults with Myeloproliferative Neoplasms: A Canadian MPN Group Study

Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study

Perioperative management of myeloproliferative neoplasms: A pan‐Canadian physician survey and international expert opinion

Correction: Upfront allogeneic transplantation versus JAK inhibitor therapy for patients with myelofibrosis: a North American collaborative study

Avapritinib Improved Skin Findings In Patients With Indolent Systemic Mastocytosis (ISM) In the Registrational, Double-Blind, Placebo Controlled PIONEER Study

Efficacy and Safety of Avapritinib in Indolent Systemic Mastocytosis (ISM): Results from the Double Blinded Placebo-Controlled PIONEER Study

Monocytosis in polycythemia vera: Clinical and molecular correlates

Canadian real-world experience of asciminib treatment in heavily pre-treated chronic myeloid leukemia (CML) patients who failed multiple lines of tyrosine kinase inhibitor (TKI) therapy

Aktive Filter

Suchergebnisse filtern